Showing results (281-290 of 336) with videos related to

Sort By:
Pageof 34
The Journal of Clinical Investigation|December 5, 2006
Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRPBalasubramanian Krishnamurthy, Nadine L Dudek, Mark D McKenzie, et al.
Pediatric Diabetes|September 29, 2022
Decreased occurrence of ketoacidosis and preservation of beta cell function in relatives screened and monitored for type 1 diabetes in Australia and New ZealandJohn M Wentworth, Helena Oakey, Maria E Craig, et al.
Clinical Trials (London, England)|August 10, 2010
Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratoriesPolly J Bingley, Alistair J K Williams, Peter G Colman, et al.
European Journal of Preventive Cardiology|September 19, 2025
The association of haptoglobin levels and phenotype with cardiovascular disease in Type 2 diabetes: a Fenofibrate Intervention and Event Lowering in Diabetes sub-studyKwok Leung Ong, Andrzej S Januszewski, Habib Francis, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 5, 2022
Lived experience of older adults with type 1 diabetes using closed-loop automated insulin delivery in a randomised trialErin Kubilay, Steven Trawley, Glenn M Ward, et al.
Diabetes Technology & Therapeutics|January 9, 2019
Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover StudyBarbora Paldus, Melissa H Lee, Hannah M Jones, et al.
Internal Medicine Journal|August 29, 2018
Hypothyroidism associated with therapy for multi-drug-resistant tuberculosis in AustraliaYee-Ming M Cheung, Karen Van, Lan Lan, et al.
Diabetes Care|November 30, 2021
Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover TrialSybil A McAuley, Steven Trawley, Sara Vogrin, et al.
The Lancet. Healthy Longevity|November 21, 2022
Glucose profiles of older adults with type 1 diabetes using sensor-augmented pump therapy in Australia: pre-randomisation results from the ORACL studySteven Trawley, Glenn M Ward, Sara Vogrin, et al.
Diabetes Technology & Therapeutics|May 16, 2022
Closed-Loop Insulin Delivery Effects on Glycemia During Sleep and Sleep Quality in Older Adults with Type 1 Diabetes: Results from the ORACL TrialAnindita Chakrabarti, Steven Trawley, Erin Kubilay, et al.
Pageof 34